Charl van Zyl is corporate vice president and commercial leader, Europe, Middle East and Africa (EMEA). He was named to this position in November 2010.
He leads Bausch + Lomb’s cross-functional, multi-market EMEA operations team with direct commercial responsibility for B+L’s emerging markets in the region.
Mr. van Zyl joined Bausch + Lomb in 2009, serving as vice president, EMEA, for the company’s Pharmaceuticals business.
Before arriving at Bausch + Lomb, Mr. van Zyl was chief executive officer for the German biotechnology firm, Jado Technologies. From 2004 to 2007 he held positions at Novartis Pharma AG as head of Marketing and Sales, Pharma Europe, and head of Global Marketing, Ophthalmics.
Early in his career Mr. van Zyl held multiple positions with Eli Lilly & Co, with responsibilities spanning across Japan, the United States, Europe and Latin America.
Mr. van Zyl graduated from the University of Cape Town with Bachelors of Science (Medicine) Honours and MBA degrees.